Seroprevalence of HBV/HCV-HIV Co-infections and outcome follow up of HAART in HIV Patients - ADAMU NDONGHO, NDIFONTIAYONG
29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
15 °P sammeln
  • Broschiertes Buch

Hepatitis B (HBV) and C (HCV) are two among the numerous forms of infections whose clinical degeneration, morbidity-mortality and low immune responsiveness in people living with human immuodeficiency virus (HIV) are highly evident. The aim of this study was to establish the prevalence of hepatitis B surface antigen (HBsAg) and hepatitis C antibody (HCVAb) among HIV-infected individuals, treatment outcomes and identified tha associated risk factors in Kumba Health, in the South West Region of Cameroon.We performed a systematic screening using RDT for HBsAg (hepatitis B surface antigent) and…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Hepatitis B (HBV) and C (HCV) are two among the numerous forms of infections whose clinical degeneration, morbidity-mortality and low immune responsiveness in people living with human immuodeficiency virus (HIV) are highly evident. The aim of this study was to establish the prevalence of hepatitis B surface antigen (HBsAg) and hepatitis C antibody (HCVAb) among HIV-infected individuals, treatment outcomes and identified tha associated risk factors in Kumba Health, in the South West Region of Cameroon.We performed a systematic screening using RDT for HBsAg (hepatitis B surface antigent) and HCVAb (hepatitis C virus antibody) among 299 HIV-positive patients enrolled at Kumba District hospital, CMA Kumba Town hospital and Banga-Bakundu Apostolic Hospital in Kumba Health District, after which positive results for HBsAg and HCVAb were further confirmed by the ELISA test and the prevalence, treatment outcomes and possible risk factors determined. A total of 52 HIV patients, 36 HIV/HBV and 12 HIV/HCV patients were then involved in the prospective cohort study for 24 months follow up. We performed CD4 counts, viral load test, analyzed ALAT/ASAT, albumin, bilirubine, creatinine.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
DR. NDIFONTIAYONG ADAMU NDONGHO has completed his PhD at the age of 33 years from Dschang University, Cameroon and is a Senior Public Health Administrator from the National School of Administration and Magistracy Yaounde. I am a Chief of Bureau Health, Data Manager and Focal Point Disease Surveillance in the South West Region of Cameroon.